🔥🐔 BizChicken 🐔🔥
Companies Similar to Artelo Biosciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Eledon Pharmaceuticals, Inc.
AT-1501
Eledon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing medicines for autoimmune diseases, amyotrophic lateral sclerosis (ALS), and organ or cell-based transplants. Its lead product candidate AT-1501 is in Phase 2 clinical trials.
Symbol: ELDN
Recent Price: $4.14
Industry: Biotechnology
CEO: Dr. David-Alexandre C. Gros M.D., Ph.D.
Sector: Healthcare
Employees: 20
Address: 19900 MacArthur Boulevard, Irvine, CA 92612
Phone: 949 238 8090
Last updated: 2024-12-31
Evelo Biosciences, Inc.
EDP1815
Evelo Biosciences, Inc. discovers and develops oral biologics for inflammatory diseases and cancer, with key products like EDP1815 in clinical trials.
Symbol: EVLO
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 66
Address: 620 Memorial Drive, Cambridge, MA 02139
Phone: 617 577 0300
Last updated: 2024-12-31
Statera Biopharma, Inc.
STAT-201, Entolimod, STAT-401, STAT-205
Statera Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and infectious diseases by rebalancing the immune system.
Symbol: STAB
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Michael Kevin Handley
Sector: Healthcare
Employees: 46
Address: 2537 Research Boulevard, Fort Collins, CO 80526
Phone: 888 613 8802
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Arcellx, Inc.
CART-dd BCMA
Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.
About | About | News | Contact | Contact | Culture | Culture | Culture | Culture | About | About | About | About | About | News
Symbol: ACLX
Recent Price: $78.35
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Sector: Healthcare
Employees: 130
Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878
Phone: 240 327 0603
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
Artelo Biosciences, Inc.
ART27.13, ART12.11, ART26.12
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing treatments that modulate the endocannabinoid system, with a pipeline including treatments for cancer-related anorexia, inflammatory bowel disease, PTSD, prostate and breast cancer.
Symbol: ARTL
Recent Price: $1.05
Industry: Biotechnology
CEO: Mr. Gregory D. Gorgas M.B.A.
Sector: Healthcare
Employees: 5
Address: 505 Lomas Santa Fe, Solana Beach, CA 92075
Phone: 858 925 7049
Last updated: 2024-12-31
Arvinas, Inc.
Bavdegalutamide, ARV-471, ARV-766
Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.
About | Leadership | Contact | Culture | Culture | Culture | About | News | Events | ESG | About | About | About | About | About | About | About | About | About | About | About | About | Events | ESG | About | About | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | Careers | About | About | About | About | News | About | About | Contact | About | About
Symbol: ARVN
Recent Price: $19.00
Industry: Biotechnology
CEO: Dr. John G. Houston Ph.D.
Sector: Healthcare
Employees: 445
Address: 5 Science Park, New Haven, CT 06511
Phone: 203 535 1456
Leadership
- John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
- Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
- Angela M. Cacace, Ph.D., Chief Scientific Officer
- Jared Freedberg, J.D., General Counsel and Corporate Secretary
- Paul McInulty, Senior Vice President, Regulatory Affairs
- John Northcott, Chief Commercial Officer
- Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
- Andrew Saik, Chief Financial Officer
- Lisa Sinclair, Senior Vice President, Corporate Operations
- Ian Taylor, Ph.D., President, R&D
- Randy Teel, Ph.D., Chief Business Officer
- Steve Weiss, Senior Vice President, Chief Human Resources Officer
Last updated: 2024-12-31
180 Life Sciences Corp.
Therapeutics for chronic pain, inflammation, fibrosis, and inflammatory diseases
1180 Life Sciences Corp. is a clinical-stage biotechnology company focused on developing therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis, using platforms such as fibrosis and anti-TNF, synthetic CBD analogs, and a7n ACh R.
Symbol: ATNF
Recent Price: $2.98
Industry: Biotechnology
CEO: Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Sector: Healthcare
Employees: 4
Address: Building 4, Palo Alto, CA 94306
Phone: 650 507 0669
Last updated: 2024-11-08
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Enveric Biosciences, Inc.
Cannabinoid Medicines
Enveric Biosciences, Inc. is a pharmaceutical company focused on developing cannabinoid medicines for cancer care, including treatments for osteoarthritis, cancer-related distress, mental health, and topical skin applications.
Symbol: ENVB
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Joseph Edward Tucker Ph.D.
Sector: Healthcare
Employees: 7
Address: 4851 Tamiami Trail North, Naples, FL 34103
Phone: 239 302 1707
Last updated: 2024-12-31
Forte Biosciences, Inc.
FB-102
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas, developing the FB-102 program for autoimmune diseases like vitiligo and alopecia areata.
Symbol: FBRX
Recent Price: $21.14
Industry: Biotechnology
CEO: Dr. Paul A. Wagner Ph.D.
Sector: Healthcare
Employees: 11
Address: 3060 Pegasus Park Drive, Dallas, TX 75247
Phone: 310 618 6994
Last updated: 2024-12-31
Palisade Bio, Inc.
LB1148
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.
Symbol: PALI
Recent Price: $1.70
Industry: Biotechnology
CEO: Mr. J. D. Finley
Sector: Healthcare
Employees: 9
Address: 5800 Armada Drive, Carlsbad, CA 92008
Phone: 858 704 4900
Last updated: 2024-12-31
Renovaro Biosciences Inc.
RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21
Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.
Symbol: RENB
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. David H. Weinstein
Sector: Healthcare
Employees: 25
Address: 2080 Century Park East, Los Angeles, CA 90067
Phone: 305 918 1980
Last updated: 2024-12-31
Vaxart, Inc.
Oral Recombinant Protein Vaccines
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant protein vaccines using a proprietary oral vaccine platform. Their product pipeline includes vaccines for norovirus, seasonal influenza, respiratory syncytial virus, and coronavirus, along with therapeutic vaccines for cervical cancer and dysplasia.
Symbol: VXRT
Recent Price: $0.69
Industry: Biotechnology
CEO: Mr. Steven Lo
Sector: Healthcare
Employees: 109
Address: 170 Harbor Way, South San Francisco, CA 94080
Phone: 650 550 3500
Last updated: 2024-12-31
Arcus Biosciences, Inc.
Cancer Therapies
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.
About | About | Leadership | Directors | About | Contact | Contact | Contact | Contact | Contact | Careers | About | About | About | About | Careers | About | Jobs | About | About
Symbol: RCUS
Recent Price: $14.91
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Sector: Healthcare
Employees: 577
Address: 3928 Point Eden Way, Hayward, CA 94545
Phone: 510 694 6200
Last updated: 2024-12-31
Arbutus Biopharma Corporation
AB-729, AB-836, AB-161, AB-101
Arbutus Biopharma Corporation is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. The company's HBV product pipeline includes RNA interference products and oral capsid inhibitors, and it is involved in strategic alliances for research and development.
About | Leadership | Directors | Contact | Contact | Culture | Jobs | Culture | About | About
Symbol: ABUS
Recent Price: $3.20
Industry: Biotechnology
CEO: Mr. Michael J. McElhaugh
Sector: Healthcare
Employees: 73
Address: 701 Veterans Circle, Warminster, PA 18974
Phone: 267 469 0914
Leadership
- Michael J. McElhaugh, Interim President and Chief Executive Officer and Director
- Michael J. Sofia PhD, Chief Scientific Officer
- Karen Sims, MD, PhD, Chief Medical Officer
- David C. Hastings, Chief Financial Officer
- Christopher Naftzger, General Counsel and Chief Compliance Officer
- Lisa Caperelli, Vice President, Investor Relations
- Shannon Briscoe, SPHR, SHRM-SCP, Vice President, Human Resources
- Frank Torti, MD, Chairman
- Daniel Burgess, Independent Director
- Richard C. Henriques, Independent Director
- Keith Manchester, MD, Independent Director
- James Meyers, Independent Director
- Melissa V. Rewolinski, PhD, Independent Director
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31